$2.030
-0.661 (-32.56%)收盤時
- 最高
- 2.730
- 開盤
- 2.110
- 成交量加權均價
- 2.08
- 成交量
- 14.34M
- 市值
- —
- 最低
- 1.480
- 成交金額
- 29.82M
- 企業價值/稅息折舊攤銷前利潤（TTM）
- 0.00
PomDoctor Ltd is a holding company principally engaged in the operation of online medical services platform for chronic diseases. The Company operates its businesses through two segments. The Internet Hospital segment includes providing online follow-up consultations and online prescription renewal service to customers and also sells prescription to customers through the website and apps. The Pharmaceutical Supply Chain segment includes pharmacy retail sales and wholesale. The Company mainly conducts its business in the domestic market.
AI 分析 of PomDoctor Ltd (POM)
賣出PomDoctor Ltd is not a good buy right now due to significant financial instability and declining stock performance. The current price is 0.63, with a staggering year-to-date change of -89.23%. Additionally, the company has a forward P/E ratio of 0, indicating no expected profitability in the near future. The main risk is the gross margin which has decreased to 13.66%, reflecting ongoing profitability pressures.
估值指標
事件時間軸
資訊
8.510-19PRnewswirePomdoctor Terminates ADR Program, Lists on Nasdaq
- 8.510-12PRnewswire
Pomdoctor Advances Predictive Healthcare Transformation
- 8.510-09PRnewswire
Pomdoctor Faces Nasdaq Delisting Risk Due to Low Share Price
- 7.509-30PRnewswire
Pomdoctor Advances AI Chronic Disease Management System
7.509-30NewsfilterPomdoctor Advances AI Chronic Disease Management System
POM 常見問題 —— 由 Alphio AI 解答
PomDoctor Ltd is a holding company principally engaged in the operation of online medical services platform for chronic diseases. The Company operates its businesses through two segments. The Internet Hospital segment includes providing online follow-up consultations and online prescription renewal service to customers and also sells prescription to customers through the website and apps. The Pharmaceutical Supply Chain segment includes pharmacy retail sales and wholesale. The Company mainly conducts its business in the domestic market. It operates in the Healthcare sector.
PomDoctor Ltd is not a good buy right now due to significant financial instability and declining stock performance. The current price is 0.63, with a staggering year-to-date change of -89.23%. Additionally, the company has a forward P/E ratio of 0, indicating no expected profitability in the near future. The main risk is the gross margin which has decreased to 13.66%, reflecting ongoing profitability pressures.
社群
更多 ↗暫無貼文
註冊或登入後參與討論本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。